Heart-type fatty acid binding protein, often shortened to H-FABP, is a blood marker released quickly when heart muscle cells are injured. It rises earlier than many older cardiac enzymes, which is why it has been studied as an early heart attack marker in people with chest pain. In modern emergency care, however, high-sensitivity troponin remains the main blood test for diagnosing heart attack. H-FABP may add context in selected settings, especially very early after symptoms begin, but it should not be used alone to confirm or rule out a heart attack.
An abnormal H-FABP result means that a clinician needs to interpret the number alongside symptoms, electrocardiogram findings, troponin changes, kidney function, and the timing of blood collection. The test can also rise with kidney disease, skeletal muscle injury, heart failure, myocarditis, pulmonary embolism, sepsis, and recent cardiac procedures.
- H-FABP measures a small protein released from injured heart muscle and, to a lesser extent, skeletal muscle.
- H-FABP can rise within about 1–3 hours after heart muscle injury, often before older markers such as CK-MB.
- A high H-FABP result does not diagnose a heart attack by itself; troponin trends and ECG findings carry more diagnostic weight.
- Many assays use cutoffs near 4–7 ng/mL, but there is no single universal normal range for every laboratory.
- Low or normal H-FABP is usually not clinically important unless it is being used in a specific emergency rule-out pathway.
- Chest pressure, shortness of breath, sweating, fainting, or pain spreading to the arm, jaw, back, or shoulder needs urgent care, not home interpretation of biomarkers.
Table of Contents
- What the H-FABP Test Measures
- When the H-FABP Test Is Used
- Timing, Sample, and Preparation
- Normal Range and Result Interpretation
- H-FABP vs Troponin and Other Cardiac Markers
- Causes of High H-FABP
- How Clinicians Use H-FABP Results
- Follow-Up, Safety, and Urgent Care
What the H-FABP Test Measures
The H-FABP test measures heart-type fatty acid binding protein in the blood. H-FABP is also called FABP3 because it is encoded by the FABP3 gene. It is a small cytoplasmic protein, meaning it sits inside cells rather than being attached to large structural muscle fibers. Its normal job is to help move long-chain fatty acids inside heart muscle cells, where fatty acids are used as an important energy source.
Heart muscle cells contain a large amount of H-FABP. When the cell membrane becomes damaged from ischemia, infarction, inflammation, pressure overload, or toxic stress, H-FABP can leak into the bloodstream. Because the protein is small, it can appear in blood quickly after injury. That fast release is the main reason H-FABP has attracted interest as an early marker of myocardial injury, which means injury to heart muscle.
H-FABP is not perfectly heart-specific. Skeletal muscle also contains it, although usually at lower concentrations than heart tissue. The kidneys help clear H-FABP from the blood, so reduced kidney function can raise baseline levels or prolong an elevation. This is one reason the test is best viewed as a supportive marker rather than a stand-alone diagnosis.
For most patients being evaluated for possible heart attack, troponin I and troponin T remain the central cardiac injury markers. H-FABP may be considered an early-release marker that can add timing information, but it does not replace clinical assessment, ECG interpretation, or serial troponin testing.
Why early release matters
A heart attack develops when blood flow to part of the heart is suddenly reduced or blocked. The faster clinicians identify true myocardial infarction, the faster they can restore blood flow and reduce damage. Early markers are attractive because some patients arrive at the emergency department within the first few hours, before certain biomarkers have clearly risen.
H-FABP can rise early because it sits freely in the cell cytoplasm. When cell membranes become leaky, it escapes quickly. This differs from larger structural proteins that may take longer to appear in high concentrations.
Even so, early does not automatically mean definitive. A marker that rises quickly can also create false alarms if it rises in other conditions. H-FABP is sensitive to tissue stress, kidney handling, and muscle injury, so clinicians must interpret it in context.
When the H-FABP Test Is Used
The H-FABP test is most often discussed in the evaluation of possible acute coronary syndrome, especially when symptoms started recently. Acute coronary syndrome includes heart attack and unstable angina, conditions caused by reduced blood flow through the coronary arteries.
In many hospitals, H-FABP is not part of the routine chest pain workup. High-sensitivity troponin protocols are now widely used because they can detect very low troponin concentrations and track small changes over 1–3 hours. Where H-FABP is available, it may be used as part of a broader cardiac biomarker panel, a research protocol, or a point-of-care testing pathway.
Clinicians may consider H-FABP when:
- Chest pain began less than 3–6 hours ago.
- The first troponin result is not clearly diagnostic.
- The ECG is not clearly normal or clearly diagnostic.
- A rapid triage tool includes H-FABP as one component.
- Prognostic information is being studied in heart attack, heart failure, chronic kidney disease, or other high-risk states.
H-FABP has also been studied in heart failure, pulmonary embolism, cardiac surgery, sepsis, and chronic kidney disease. In these settings, it may reflect myocardial stress, silent injury, or increased risk rather than a classic plaque-rupture heart attack.
What the test cannot do
H-FABP cannot tell by itself whether a blocked coronary artery is present. It cannot show which artery is involved, how large the damaged area is, or whether a patient needs a stent. It also cannot distinguish all causes of heart injury from one another.
For example, myocarditis can injure heart muscle without a blocked artery. Severe anemia, rapid heart rhythm, very low blood pressure, or severe respiratory failure can strain the heart and cause injury from oxygen supply-demand imbalance. Kidney disease can keep H-FABP elevated even when the main issue is reduced clearance rather than a new heart attack.
That is why the test is interpreted beside symptoms, physical examination, ECG, troponin pattern, kidney function, and sometimes imaging such as echocardiography or coronary angiography.
Timing, Sample, and Preparation
H-FABP is measured from a blood sample, usually drawn from a vein. Some point-of-care versions use rapid immunoassay methods that provide a positive or negative result, while laboratory assays may report a numeric concentration in ng/mL. The method matters because different assays can use different cutoffs.
No special preparation is usually needed. In emergency settings, the sample is drawn immediately because timing is part of the interpretation. Fasting is not required. A patient should not delay urgent care to prepare for the test.
The timing pattern of H-FABP is one of its main features. It often becomes detectable early after myocardial injury, tends to peak within the first several hours, and may fall sooner than troponin because it is a small protein cleared partly through the kidneys.
| Marker | Common rise after injury | Common peak | Common return toward baseline | Main use |
|---|---|---|---|---|
| H-FABP | About 1–3 hours | About 4–8 hours | Often within 12–24 hours | Early supportive marker of heart muscle injury |
| High-sensitivity troponin | Often within 1–3 hours, depending on assay and injury size | Often 12–24 hours or later | Can remain elevated for days | Main diagnostic marker for myocardial injury and heart attack |
| CK-MB | About 3–6 hours | About 12–24 hours | Usually 2–3 days | Older cardiac enzyme marker, now less central |
| Myoglobin | About 1–2 hours | About 6–9 hours | Often within 24 hours | Early muscle injury marker with low heart specificity |
These timeframes are approximate. The actual pattern depends on the size of injury, blood flow restoration, kidney function, assay sensitivity, and when symptoms truly began. People often misjudge the start of symptoms, especially when discomfort builds gradually, comes and goes, or appears as shortness of breath, nausea, fatigue, or upper abdominal pressure rather than classic crushing chest pain.
Serial testing is often more useful than one result. A rising or falling pattern can show that an injury is acute, while a stable elevation may suggest chronic myocardial stress, kidney-related elevation, or a non-acute process.
Normal Range and Result Interpretation
There is no single universal H-FABP normal range that applies to every laboratory. Many studies and assays describe healthy values in the low single-digit ng/mL range. Some laboratory methods use an upper reference limit near 5 ng/mL, while some point-of-care or study cutoffs fall around 4–7 ng/mL. Other assays use their own decision thresholds.
The safest way to read a result is to use the reference interval printed on the lab report. A result marked high by one assay may not be directly comparable with a result from another assay.
| Result pattern | Common meaning | Important caution |
|---|---|---|
| Within the lab reference range | No clear H-FABP evidence of recent muscle or heart injury at that sampling time | Very early testing can still miss evolving injury; symptoms and troponin protocol matter |
| Mildly high | Possible early heart injury, chronic heart stress, kidney-related elevation, or skeletal muscle contribution | Needs comparison with troponin, ECG, creatinine/eGFR, and repeat testing |
| Clearly high with chest pain | Raises concern for acute myocardial injury, especially if symptoms are recent | Still does not prove type 1 heart attack without ischemic evidence |
| Falling after a previous high result | Can fit an earlier injury pattern because H-FABP clears relatively quickly | Troponin may still be rising while H-FABP is falling |
| Persistently high | May suggest ongoing injury, chronic heart disease, impaired kidney clearance, or repeated muscle stress | Requires clinical review rather than a single-marker conclusion |
A “negative” or normal H-FABP result does not always rule out heart attack. It depends on the timing of symptoms, the assay used, the patient’s risk level, the ECG, and whether high-sensitivity troponin has been checked at the correct intervals.
A high result also does not automatically mean a blocked artery. It means H-FABP has entered the blood in a pattern that deserves explanation. The explanation may be a heart attack, but it may also be another cause of heart strain, muscle injury, or reduced kidney clearance.
Low H-FABP results
Low H-FABP is not usually a medical problem. Unlike some hormones or nutrients, H-FABP is not measured to detect deficiency. A low value is generally interpreted as no measurable elevation by that assay.
The only reason a low value becomes clinically important is when it is part of an emergency rule-out pathway. Even then, clinicians do not rely on the H-FABP result alone. They combine it with symptoms, ECG, risk score, and troponin results.
H-FABP vs Troponin and Other Cardiac Markers
Troponin is the preferred blood marker for diagnosing myocardial injury. High-sensitivity troponin assays can detect very small amounts of troponin and help clinicians classify patients into rule-out, observe, or rule-in groups. H-FABP may rise quickly, but it has not replaced troponin because it is less specific and less standardized.
The most helpful way to compare the markers is to separate speed from diagnostic authority. H-FABP may be fast. Troponin is more central to the formal diagnosis of myocardial injury and myocardial infarction.
High-sensitivity troponin testing is especially important because the diagnosis of heart attack depends not only on an elevated marker but also on evidence of acute ischemia. That evidence may include ischemic symptoms, new ECG changes, imaging evidence, angiographic findings, or a clear rise and/or fall in troponin. For a deeper explanation of low-level troponin changes, see high-sensitivity troponin interpretation.
| Test | Strength | Main limitation | Current role |
|---|---|---|---|
| H-FABP | Early release after myocardial injury | Not fully heart-specific; affected by kidney function | Supportive or investigational marker in many settings |
| High-sensitivity troponin I or T | Best-established marker for myocardial injury | Can be elevated in many non-heart-attack conditions | Main blood test in suspected heart attack protocols |
| CK-MB | Can show a rise and fall after muscle injury | Less sensitive and less specific than troponin | Older cardiac enzyme, sometimes used when troponin interpretation is difficult |
| Myoglobin | Very early muscle injury marker | Poor heart specificity | Limited role; more useful as a general muscle injury signal |
| BNP or NT-proBNP | Reflects heart wall stress and heart failure risk | Does not diagnose heart attack | Used for suspected heart failure and prognosis |
H-FABP and CK-MB are sometimes discussed together because both have been used in cardiac enzyme panels. CK-MB rises later than H-FABP and is less specific than troponin, but it may still appear in certain lab protocols. A more detailed comparison is available in CK-MB and troponin patterns.
H-FABP also overlaps with myoglobin because both are early-release markers. Myoglobin rises very quickly after muscle injury, but it comes from skeletal muscle as well as heart muscle. H-FABP is usually more heart-enriched than myoglobin, but neither marker has the diagnostic authority of troponin. When muscle breakdown or kidney risk is part of the picture, myoglobin results may help clarify the broader muscle injury pattern.
Causes of High H-FABP
High H-FABP usually means recent or ongoing cell injury, but the source is not always a classic heart attack. The most concerning cause is acute myocardial infarction, especially when the person has chest pressure, shortness of breath, sweating, nausea, faintness, or pain spreading to the arm, jaw, back, or shoulder.
Other heart-related causes can also raise H-FABP. Myocarditis, which is inflammation of the heart muscle, can damage cardiac cells. Acute heart failure can stretch and stress the heart. A rapid heart rhythm can increase oxygen demand. Severe high blood pressure can strain the heart. Pulmonary embolism can overload the right side of the heart. Cardiac surgery, cardioversion, ablation, and other procedures can cause temporary myocardial injury.
Non-cardiac factors matter too. Skeletal muscle injury can contribute to H-FABP because skeletal muscle contains the protein. Strenuous exercise, trauma, seizures, prolonged immobilization, or rhabdomyolysis can raise muscle-related markers. In these cases, clinicians often compare H-FABP with creatine kinase, myoglobin, creatinine, urine findings, and symptoms. For larger muscle injury patterns, CK and myoglobin interpretation is often more useful than H-FABP alone.
Kidney function is another major factor. H-FABP is small and partly cleared through the kidneys. When kidney function is reduced, the level may be higher at baseline or remain elevated longer. A person with chronic kidney disease may therefore have an H-FABP result that needs cautious interpretation. In many cases, clinicians check creatinine and eGFR at the same time.
Common causes of high H-FABP include:
- Acute myocardial infarction.
- Unstable angina or acute coronary syndrome with myocardial stress.
- Myocarditis or inflammatory heart injury.
- Acute or chronic heart failure.
- Pulmonary embolism with right-heart strain.
- Cardiac surgery, angioplasty, ablation, cardioversion, or trauma.
- Severe sepsis, shock, hypoxia, or respiratory failure.
- Skeletal muscle injury, intense exercise, seizures, or rhabdomyolysis.
- Chronic kidney disease or acute kidney injury.
- Some severe systemic illnesses that stress the heart.
A high H-FABP result should answer one immediate question: is there evidence of acute heart injury that needs urgent action? It should not be reduced to a yes-or-no heart attack label without the rest of the clinical picture.
How Clinicians Use H-FABP Results
Clinicians use H-FABP as one piece of a time-sensitive pattern. The same number can mean different things depending on when the blood was drawn, what symptoms are present, and whether other markers are rising or falling.
A patient who develops crushing chest pressure 90 minutes before arrival, has a suspicious ECG, and shows high H-FABP needs rapid evaluation even if the first troponin is not yet clearly high. A different patient with chronic kidney disease, no chest pain, stable troponin, and mildly elevated H-FABP may need a slower outpatient or inpatient evaluation for chronic myocardial stress rather than emergency catheterization.
Serial testing often clarifies the situation. An acute injury usually produces a change over time. A single stable value can be harder to interpret. With H-FABP, a rise and fall may happen earlier than troponin, so the timing of repeat samples matters.
Pattern examples
One common early-injury pattern is recent chest pain with a normal or borderline troponin, high H-FABP, and an ECG that is abnormal but not definitive. This pattern may push clinicians to repeat troponin quickly, observe the patient closely, and consider imaging or cardiology review.
Another pattern is high troponin with normal H-FABP many hours after symptoms started. This can happen because H-FABP may have already peaked and fallen while troponin remains elevated. In that setting, a normal H-FABP does not cancel out the troponin result.
A third pattern is mildly high H-FABP with high creatinine and no clear ischemic symptoms. This may reflect reduced kidney clearance or chronic heart strain. Clinicians still take it seriously, but they usually avoid diagnosing acute myocardial infarction without supportive evidence.
A fourth pattern is high H-FABP with high CK and high myoglobin after a fall, seizure, or extreme exercise. This points toward skeletal muscle injury as a possible contributor. The immediate safety issue may be kidney injury from rhabdomyolysis rather than coronary artery blockage.
Why ECG and symptoms still matter
Blood tests do not replace an ECG in suspected heart attack. Some patients with ST-elevation myocardial infarction need urgent reperfusion treatment before a full biomarker pattern develops. Other patients may have non-ST-elevation myocardial infarction, where serial troponin and clinical risk assessment are central.
Symptoms also guide urgency. Chest discomfort may not feel like sharp pain. It may feel like pressure, squeezing, heaviness, burning, indigestion, or breathlessness. Older adults, people with diabetes, and some women may have less typical symptoms, including fatigue, nausea, sweating, dizziness, or unexplained shortness of breath.
H-FABP can support early suspicion, but emergency decisions depend on the whole presentation.
Follow-Up, Safety, and Urgent Care
A high H-FABP result should be reviewed by a clinician, especially if it was ordered because of chest pain, shortness of breath, fainting, palpitations, or suspected heart injury. The next step depends on the setting.
In an emergency department, follow-up may include repeat troponin testing, repeat ECGs, kidney function tests, electrolytes, complete blood count, chest imaging, echocardiography, stress testing, CT coronary angiography, or invasive coronary angiography. Treatment may include antiplatelet therapy, anticoagulation, oxygen when needed, rhythm control, blood pressure treatment, or urgent coronary intervention.
In an outpatient setting, H-FABP is less commonly used. If an outpatient result is unexpectedly high, the clinician will usually ask about symptoms, timing, kidney disease, recent exercise, injuries, procedures, infection, and medications. They may repeat the marker, check troponin, assess kidney function, or refer to cardiology depending on the circumstances.
Urgent medical care is needed if any of the following occur:
- Chest pressure, tightness, squeezing, heaviness, or pain lasting more than a few minutes.
- Pain spreading to the arm, shoulder, jaw, neck, back, or upper abdomen.
- Shortness of breath, sweating, nausea, or sudden weakness with chest discomfort.
- Fainting, near-fainting, confusion, or a new irregular heartbeat.
- New severe symptoms in someone with known coronary artery disease, heart failure, diabetes, kidney disease, or prior heart attack.
- A high H-FABP result together with current or recent symptoms suggestive of acute coronary syndrome.
Do not wait for a planned appointment when symptoms suggest a possible heart attack. Biomarker interpretation is safest when it happens in real time with ECG monitoring and repeat blood testing.
Questions to ask about an H-FABP result
A useful discussion with a clinician may include:
- What was the lab’s reference range or cutoff?
- Was the result measured by a rapid qualitative test or a quantitative assay?
- How many hours had passed since symptoms began?
- What were the troponin I or troponin T results, and did they change over time?
- Was the ECG normal, abnormal, or changed from a prior ECG?
- What were the creatinine and eGFR results?
- Could recent exercise, injury, surgery, infection, or kidney disease explain the result?
- Is repeat testing or cardiology follow-up needed?
H-FABP is most useful when it sharpens a broader clinical picture. It is least useful when interpreted as an isolated number without timing, symptoms, kidney function, and troponin context.
References
- 2023 ESC Guidelines for the management of acute coronary syndromes 2023 (Guideline)
- 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines 2021 (Guideline)
- Diagnostic and Prognostic Evaluation of Novel Biomarkers Compared to ESC 0/1 h and 0/3 h Algorithms in Patients with Suspected Non-ST-Elevation Myocardial Infarction 2025 (Clinical Study)
- Neutrophil lymphocyte ratio and heart type fatty acid binding protein as a prognostic marker in Myocardial infarction within 48 h of admission 2024 (Clinical Study)
- Importance of H-FABP in early diagnosis of acute myocardial infarction 2024 (Clinical Study)
- Heart-Type Fatty Acid Binding Protein, Cardiovascular Outcomes, and Death: Findings From the German CKD Cohort Study 2022 (Cohort Study)
Disclaimer
H-FABP results should be interpreted by a qualified healthcare professional in the context of symptoms, ECG findings, troponin results, kidney function, and medical history. A normal result does not always rule out a heart attack, and a high result does not prove one. Seek urgent medical care for chest pressure, shortness of breath, fainting, sweating, or pain spreading to the arm, jaw, back, or shoulder.
